DiaMedica Therapeutics Inc. (DMAC) Balance Sheet
As of 2026-06-30 (10-Q), DiaMedica Therapeutics Inc. (DMAC) reported total assets of $45.0M and shareholders' equity of $38.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $5.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DMACDiaMedica Therapeutics Inc.Follow DMAC — free
—
Price chart with a free account
- Market cap
- 470.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.4 | 16.8 | 3.9 | 7.4 | 4.7 | 4.7 | 4.5 | 3.0 | 15.6 | 5.1 | |
| Short-term investments | — | — | 4.0 | 20.1 | 40.4 | 28.8 | 48.4 | 41.1 | 44.2 | 38.4 | |
| Receivables | 0.1 | 0.8 | 0.8 | 0.3 | 0.1 | 0.1 | 0.4 | 0.2 | 0.3 | 0.2 | |
| Current assets | 1.5 | 18.0 | 8.8 | 27.9 | 45.4 | 33.8 | 53.7 | 44.6 | 60.6 | 44.3 | |
| Total assets | 1.8 | 18.3 | 9.1 | 28.1 | 45.6 | 34.4 | 54.2 | 46.3 | 61.4 | 45.0 | |
| Current liabilities | 1.0 | 1.3 | 1.3 | 2.0 | 1.5 | 2.2 | 2.8 | 5.4 | 5.1 | 6.6 | |
| Shareholders' equity | 0.8 | 17.0 | 7.6 | 26.0 | 44.0 | 31.8 | 51.1 | 40.7 | 56.1 | 38.3 |
USD millions · SEC XBRL
DiaMedica Therapeutics Inc. — questions
- How much cash does DiaMedica Therapeutics Inc. have?
- $5.1M in cash and cash equivalents as of 2026-06-30.
- What are DiaMedica Therapeutics Inc.'s total assets?
- $45.0M as of 2026-06-30.
- What is DiaMedica Therapeutics Inc.'s shareholders' equity?
- $38.3M as of 2026-06-30.
Every figure on this page comes from DiaMedica Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.